This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2008
Title: Teresa Damiano: Innovator in Therapeutic Chemistry
Introduction
Teresa Damiano is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic chemistry, particularly in oncology. With a total of 2 patents to her name, her work focuses on novel compounds that have the potential to improve cancer treatment.
Latest Patents
Her latest patents include the development of substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines. These compounds are notable for their therapeutic activity and can be utilized in various oncology applications. The inventions relate specifically to compositions comprising these novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, which hold promise for advancing cancer therapies.
Career Highlights
Teresa Damiano is currently associated with Aventis Pharma S.A., where she continues to innovate in the pharmaceutical sector. Her work has garnered attention for its potential impact on cancer treatment methodologies.
Collaborations
Throughout her career, Teresa has collaborated with notable colleagues, including Fabienne Thompson and Catherine Souaille. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Teresa Damiano's contributions to therapeutic chemistry, particularly in oncology, highlight her role as an influential inventor. Her innovative work continues to pave the way for new treatments in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile